Background--Balloon postdilation (BPD) has emerged as an effective strategy to reduce paravalvular regurgitation (PVR) during transcatheter aortic valve replacement (TAVR). We investigated the utility of a time-integrated aortic regurgitation index (TIARI) to guide balloon postdilation (BPD) after valve deployment.
T ranscatheter aortic valve replacement (TAVR) is now a widely accepted alternative to surgical replacement among patients with symptomatic severe aortic stenosis in patients with intermediate-to-high surgical risk. 1, 2 However, significant residual paravalvular regurgitation (PVR) after TAVR continues to be linked to higher short-and medium-term mortality. [3] [4] [5] Hence, current practices include placing a second valve or balloon postdilation (BPD) to reduce PVR. 6 Indeed, a recent meta-analysis demonstrated that BPD was associated with a 15-fold reduction in the incidence of moderate-to-severe PVR among patients undergoing TAVR. 7 However, currently there is a lack of consensus on the intraoperative parameters guiding BPD after valve deployment during TAVR. Part of the challenge lies in the fact that despite improvements in imaging modalities, accurate intraoperative quantification of PVR remains a clinical dilema. The evaluation of PVR is challenging with the use of intraprocedural transesophageal echocardiography (TEE) because of the following considerations: (1) it is difficult to align the aortic annulus using TEE; and (2) acoustic shadows from the prosthetic valve or residual calcium can preclude PVR assessment. 8 Moreover, recent studies have demonstrated that use of minimal to no sedation during TAVR is associated with better hemodynamic stability, fewer respiratory and cardiovascular risks, shorter TAVR duration, quicker identification of any neurological sequelae, and lower complication rates along with shorter hospital stay. [8] [9] [10] These observations have led to increased adoption of minimal sedation during TAVR and precluded the use of TEE for evaluation of PVR. Other studies seem to suggest that angiography correlates better with PVR than echocardiography. 11 Although angiographic evaluation of PVR has its advantages, it has higher intra-and interobserver variability and moderately correlated with PVR assessed using cardiac magnetic resonance imaging. 12, 13 Indeed, the consensus document from the Valve Academic Research Consortium also failed to mention a criterion standard test to measure PVR. 14 Hence, recent reports have suggested the use of a multimodality approach: combining imaging and hemodynamic indices for accurate assessment of PVR. 6, 15 Sinning et al demonstrated that hemodynamic assessment, specifically aortic regurgitation index (ARI), provided improved estimation of PVR severity and demonstrated prognostic significance. 6 This index was further modified by integrating systolic time and diastolic time. The resulting timeintegrated aortic regurgitation index (TIARI) was less susceptible to changes in heart rate. 16 demonstrated that another hemodynamic index (DPTI) generated by dividing the duration of diastole from the area between aortic (Ao) and left ventricular (Lv) pressure-time curves showed a stepwise decrease in value with increasing PVR when adjusted for scaling of pressure-time curve and systolic blood pressure. However, to date there are no data on the utility of catheterderived hemodynamic indices and intraoperative imaging modalities to guide BPD among patients undergoing TAVR. Consequentially, we hypothesized that combining a catheterbased hemodynamic index (TIARI) with intraoperative echocardiography and angiography would be better to guide BPD when compared with any modality alone. We also investigated the prognostic value of residual TIARI after TAVR.
Methods
The data that support the findings of the study are available from the corresponding author upon reasonable request.
Patient Selection
We selected all consecutive patients from our prospective institutional TAVR registry who underwent TAVR for severe aortic stenosis between October 2015 and August 2016 and had analyzable hemodynamic tracings recorded immediately after valve deployment. The study protocol was approved by the Cleveland Clinic Institutional Review Board with a waiver of informed consent and data were de-identified.
Echocardiographic Evaluation of Paravalvular Regurgitations
Transthoracic echocardiography or TEE was performed immediately after valve deployment. Three consecutive cardiac 
Clinical Perspective
What Is New?
• The results of our study demonstrate that a catheter-based hemodynamic parameter-time-integrated aortic regurgitation index-could help guide management of significant paravalvular regurgitation using balloon postdilatation.
• While time-integrated aortic regurgitation index predicted mortality after transcatheter aortic valve replacement, other imaging modalities did not.
What Are the Clinical Implications?
• Real-time assessment of paravalvular regurgitation after valve deployment is necessary to guide management of paravalvular regurgitation.
• The results of our study indicate the need for operators to utilize a more quantitative index (eg, time-integrated aortic regurgitation index) to quantify paravalvular regurgitation intraoperatively. 
Angiographic Evaluation of Paravalvular Regurgitations
Aortography was performed in biplane views including right anterior oblique 30°and left anterior oblique 60°view after valve deployment, by injecting 20 mL of 50:50 diluted dye in 1 s. Aortographic grading of PVR (grades 0-IV) was done by an experienced angiographer (K.S.) who was blinded to all clinical, echocardiographic, and hemodynamic data according to the criteria described by Sandler et al; grade 0 (no PVR)=no regurgitating contrast into the left ventricle (LV); grade I (mild PVR)=a small amount of contrast enters the LV in diastole and is cleared with each beat; grade II AR (moderate PVR)=faint opacification of the entire LV; grade III (moderately severe PVR): opacification of the entire LV to the same degree as the ascending aorta; grade IV (severe PVR): complete, dense opacification of the LV on the first beat and more densely opacified than the ascending aorta. 18 
Hemodynamic Measurements
Detailed derivation of ARI, TIARI, and DPTI have been described before. 16, 17, 19 Briefly: on achieving stable hemodynamics after deploying a transcatheter valve, LV and Ao invasive pressures were measured simultaneously. Pre-BPD and post-BPD Ao and LV systolic and diastolic pressures were quantified using AXIOM Sensis XP hemodynamic software (Siemens AG, Forcheim, Germany). Area between Ao and LV pressure-time curves during diastole were measured. Area under LV pressuretime curve during systole was also measured. Following pre-BPD and post-BPD, hemodynamic indices were computed offline by a blinded reviewer (R.G.) as follows ( Figure 1 ):
Balloon Postdilation After Valve Deployment
The intraoperative requirement for BPD after transcatheter valve deployment was decided by 2 experienced TAVR operators (S.K., A.K.) based on their expert clinical judgment. These operators did not have calculated TIARI index for decision making and all hemodynamic indices were calculated offline later as described above.
Statistical Analysis
Continuous data were expressed as meanAESD when normally distributed, or median (interquartile range) otherwise. An unpaired t test or Mann-Whitney test was used to compare hemodynamic, angiographic, and echocardiographic variables as appropriate. We performed logistic regression model analysis to assess the association between BPD and hemodynamic, angiographic, and echocardiographic assessment of PVR. In the multivariable model, all relevant variables (ARI, TIARI, DPTI, and PVR grade by aortic root angiography or echocardiography) were entered in a forward stepwise manner. Optimal cutoff value of TIARI to predict BPD was obtained from the receiver operating characteristic curve. We also calculated C-statistics, continuous net reclassification improvement, and integrated discrimination improvement from a logistic regression model. 18, 19 Incremental prognostic value was also assessed with a statistically significant 
Results

Study Population
We identified 247 consecutive patients with severe aortic stenosis who underwent TAVR from October 2015 to August 2016. Baseline features of 157 patients who had catheterderived hemodynamic tracings recorded immediately after valve deployment are shown in Table 1 . A total of 88 (56%) patients had TEE after valve placement while the rest had transthoracic echocardiography. Almost all (n=152, 98%) patients in this cohort had an aortogram recorded after valve placement. In total, 49 (31%) patients required BPD to reduce significant PVR after valve deployment. No patient required a second valve deployment after TAVR to reduce severe PVR.
Most procedures were performed using the Edwards SAPIEN 3 valve (n=128, 82%) while the XT valve was used in 5 patients (3%) and the Medtronic Core Valve in 17 patients (11%), St Jude Medical Portico in 2 patients, Lotus Valve System in 1 patient, and Direct Flow Medical valve system in 4 patients. When compared with patients requiring BPD, patients who did not require BPD demonstrated similar pre-TAVR hemodynamic and echocardiographic estimations. Among patients who required BPD, we observed significantly lower ARI, TIARI, and DPTI after valve deployment (P<0.001 for all) when compared with patients who did not require BPD. Furthermore, ARI, TIARI, and DPTI significantly increased along with decrease in the number of patients with severe aortographic and echocardiographic PVR after BPD (P<0.001 for all) ( Table 2 ). Figure 2 (Video S1) demonstrates a patient with low TIARI after valve deployment along with moderate PVR on TEE and aortography. TIARI increased after BPD along with reduction of PVR by both aortography and TEE.
Incremental Ability of Hemodynamic Assessment to Predict BPD
Among 157 patients, lower ARI, TIARI, and DPTI along with higher PVR grade on aortography or echocardiography after valve deployment predicted BPD (Table 3 ). In multivariable logistic regression analysis, lower TIARI (odds ratio [OR]: 0.81, P=0.003) after valve deployment along with higher PVR grade by aortography (OR: 133, P<0.001) and echocardiography (OR: 56, P<0.001) were selected to predict BPD by forward stepwise model. Interestingly, ARI and DPTI were not selected to predict BPD in the multivariable analysis.
The optimal cut-off value of TIARI (computed after valve deployment) to predict BPD was found to be 45.5 (Cstatistics=0.74, sensitivity=75%, specificity=65%) ( Table 4) . Adding TIARI to aortography and echocardiography improved the prediction model with integrated discrimination improvement of 9% (P=0.002) and combined C-statistics of 0.99 to predict BPD (Table 5, Figure 3) . Similarly, adding TIARI to echocardiography and aortography also resulted in a significant increase in the global v 2 for the model predicting BPD (P<0.001 for TIARI) (Figure 4 ).
Association of Hemodynamic Variables With PVR Severity Using Imaging Modalities
All calculated hemodynamic indices (ARI, TIARI, and DPTI) showed weak but significant correlation with PVR severity on aortographic evaluation, while only TIARI and DPTI showed significant correlation with echocardiographic PVR grade ( Table 6 ). Among 157 patients with pre-and postvalve deployment hemodynamic assessment, 77 patients had no or trivial PVR by echocardiography before TAVR. Among these 77 patients, changes in TIARI between pre-and postvalve deployment (DTIARI) was still significantly associated with BPD (P=0.021, OR 0.92, 95% CI: 0.85-0.99).
To further investigate the value of TIARI in diagnosing PVR after valve placement, we divided the patient cohort based on pre-and post-TAVR echocardiographic PVR grades. In patients with no PVR before TAVR, who also did not demonstrate any PVR by echocardiography postvalve deployment, the median TIARI increased from 41 (36-47) to 47 (43-55) postvalve deployment (Table 7) . Only 2 (5%) of these patients required BPD after valve deployment. In addition, among patients with no PVR before TAVR who then developed at least mild PVR postvalve deployment, the median TIARI increased from 37 (33-42) to 44 (38-52) after valve deployment. As many as 20 (74%) patients required BPD after valve deployment in this subgroup of patients. After valve deployment, TIARI increased from 38 (31-49) to 48 (44-53) in patients with at least mild echocardiographic PVR before undergoing a TAVR; these patients then had no PVR postvalve deployment by echocardiography. Only 3 (5%) of these patients required a BPD after valve placement. Furthermore, among patients with some degree of echocardiographic grade PVR before TAVR, who then had some degree of PVR after valve deployment, TIARI increased from 37 (33-47) to 45 (40-50) postvalve deployment. 
Association of Hemodynamic Variables With Prognosis
Among 157 patients with hemodynamic tracings after valve deployment, the median follow-up period was 605 days (interquartile range: 520-689) and 22 patients (16%) died. To accurately investigate the association of PVR with mortality, we measured PVR using imaging and hemodynamic modalities after valve deployment in patients who did not require BPD. In patients who required BPD, PVR assessment using imaging and hemodynamic modalities was done after BPD. In Cox proportional hazards model analysis, only higher residual TIARI after TAVR significantly predicted better survival rates (hazard ratio 0.94, P=0.023; Table 8 ), while other hemodynamic parameters (ARI, DPTI) were not associated with mortality. PVR grade by angiography or echocardiography were also not predictive of mortality after TAVR. TIARI predicted mortality even after adjusting for possible confounding factors (hazard ratio 0.94, 95% CI: 0.89-0.99, P=0.014). 
Discussion
In patients undergoing TAVR, we analyzed intraoperative hemodynamic tracings and echocardiographic and aortographic images immediately after valve deployment and demonstrate that (1) all catheter-derived hemodynamic indices (ARI, TIARI, and DPTI) were significantly lower in patients who required BPD when compared with those who did not require BPD. (2) 
Prognostic Value of Hemodynamic Indices Among Patients Undergoing TAVR
In patients undergoing TAVR, moderate-to-severe PVR after prosthetic aortic valve deployment is a frequent complication associated with adverse outcomes and might be caused by (1) underexpanded prosthetic stent frame; (2) inadequate apposition against the native aortic annulus such as in heavily calcified cusps; (3) patient-prosthetic mismatch; and (4) inappropriate implantation depth. 21 We demonstrate that hemodynamic assessment of residual PVR among patients undergoing TAVR might be of prognostic value. Sinning et al 22, 23 demonstrated that patients with low post-TAVR ARI had a higher 1-year mortality rate. Additionally, Collas et al 19 compared hemodynamic measurements with echocardiographic and aortographic assessment of PVR after TAVR in a prospective cohort of 111 high-risk patients. These authors found no concordant relationship between ARI and echocardiographic and angiographic assessment of post-TAVR PVR. Furthermore, no prognostic information was found by assessing PVR by angiography or by ARI. In contrast, echocardiographic grading of PVR showed high observer reproducibility and provided prognostic value in selecting patients with decreased survival at 1 year. 19 Of note, these studies were done purely on self-expandable transcatheter valves and generally among higher-risk patients undergoing TAVR. More recently, DPTI was found to be the strongest predictor of 1-year mortality among 362 patients who underwent TAVR during the years 2009 to 2012 using either self-expandable or balloon-expandable valves. 17 However, the above studies did not investigate the value of catheter-derived hemodynamic indices to guide effective treatment strategies of PVR such as BPD. Our cohort of patients includes a very contemporary population of high-, low-, and intermediate-risk patients, who received valves with improved designs. Hence, it is probably not surprising that no patients had a residual PVR that was graded as "severe" by either echocardiography or aortographic after valve deployment in our study. Furthermore, only 2 patients had moderate PVR by echocardiography, while none had moderate PVR by aortography after valve deployment. Consequently, it is important to note that only residual TIARI predicted significant all-cause mortality after TAVR. Indeed, the degree of PVR with the newer generation valves might be too low to be accurately diagnosed by echocardiography or angiography, and hence we need a more quantitative assessment of PVR as provided by a catheter-based hemodynamic index that could be obtained in real time as the procedure is performed. 24 
Limitations
While we selected patients from our prospective institutional TAVR registry, all hemodynamic indices were calculated offline in retrospect. Final analysis was done only on 157/ 247 patients who had catheter-derived hemodynamic tracings recorded immediately after valve deployment. It is possible that we selected a cohort of patients who were at higher risk of PVR and hence underestimated the clinical value of catheter-derived hemodynamic indices in guiding BPD. While the results of our study are hypothesis generating, larger prospective studies investigating the value of utilizing TIARI as a deferral strategy either alone or in combination with other imaging modalities are required among patients who develop significant PVR after valve deployment during TAVR.
Conclusion
TIARI calculated immediately after valve deployment provides incremental information over aortography and echocardiography to predict BPD among patients undergoing TAVR. Patients who demonstrated lower residual TIARI after TAVR demonstrated higher mortality rates.
